GRI Bio GRI
NASDAQ GRI
$1.65 -0.02 (-1.20%)
At close: Aug 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) Other Non Operating Income (2021 - 2024)

GRI Bio (GRI) posted quarterly Other Non Operating Income of $1000.0 for Q2 2024, down 99.18% year-over-year from $122000.0 in Q3 2023, and down 50.0% quarter-over-quarter from $2000.0 in Q1 2024.

GRI Bio (GRI) Other Non Operating Income (2021 - 2024) Analysis & Trends

GRI Bio's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $1000.0 for Q2 2024.

  • In Q2 2024, Other Non Operating Income fell 99.18% year-over-year to $1000.0; the TTM figure through Mar 2025 stood at $1000.0 (down 99.46% YoY), while the FY2024 annual figure was $3000.0, down 98.35% from the prior year.
  • Other Non Operating Income for Q2 2024 stood at $1000.0, down from $2000.0 in the prior quarter.
  • The five-year high for Other Non Operating Income was $122000.0 in Q2 2023, with the low at $1000.0 in Q2 2024.
  • The 3-year median for Other Non Operating Income is $30500.0 (2023), against an average of $41166.7.
  • Peak annual rise in Other Non Operating Income reached 99.18% in 2024, while the deepest fall reached 99.18% in 2024.
  • GRI Bio's Other Non Operating Income stood at $61000.0 in 2021, then slumped by 75.41% to $15000.0 in 2023, then plunged by 93.33% to $1000.0 in 2024.
  • Business Quant data shows GRI's Other Non Operating Income at $1000.0 in Q2 2024, $2000.0 in Q1 2024, and $15000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 GRI Bio 3.01 Mn 3.01 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2024 1,000.00
Mar 31, 2024 2,000.00
Dec 31, 2023 15,000.00
Sep 30, 2023 46,000.00
Jun 30, 2023 122,000.00
Mar 31, 2021 61,000.00